Medical News

ESRD Indicates Worse Prognosis in Hospitalized HF Patients

Heart failure (HF) patients with end-stage renal disease (ESRD), have substantially increased in-hospital mortality, reported a recent study. In...

21 Aug, 2018

 
Email this page
Statin Therapy Beneficial in ACS Survivors Irrespective of their Baseline LDL-C

Low-to-moderate intensity statin treatment mitigates the risk of major adverse cardiovascular events (MACEs) and all-cause mortality at 12 months...

11 Aug, 2018

 
Email this page
Strong and Independent Association Between Female STEMI Patients and Non-Chest Pain Presentation

A recent study revealed remarkable gender differences in symptomatology of ST-segment elevation myocardial infarction (STEMI) patients. Females were...

10 Aug, 2018

 
Email this page
Age, A Predictor of Survival Outcomes in PAH Patients Initially Treated with Oral ERA or PDE5i Monotherapy

Initial treatment with oral endothelin receptor blocker (ERA) or phosphodiesterase-5 inhibitor (PDE5i) was associated with similar long term...

06 Aug, 2018

 
Email this page

Key Trials

Sacubitril/Valsartan vs. Enalapril in HFrEF Patients: Analyzing the Renal Impact and Associated Outcomes

The study analyzes renal effects and the associated outcomes of sacubitril/valsartan vs. enalapril in HF patients with reduced ejection fraction.  

Treatment with Macitentan Reduces Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension – SERAPHIN Study

Results of the SERAPHIN study demonstrated that treatment with macitentan resulted in significant reduction in morbidity and mortality in patients...

Initiation/Uptitration of Sacubitril/Valsartan in HFrEF Patients: Insights from the TITRATION Trial

The TITRATION trial assessed tolerability of initiating/uptitrating sacubitril/valsartan using a conservative or condensed regimen in HFrEF patients...

Evidence with Telmisartan Translated to Real World

As per this study, selectively created non-randomized real-world data might be valuable in establishing supplemental drug indications of medication...

Slide Library

Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page
Ambrisentan in PAH

Ambrisentan is a propanoic acid, non-sulfonamide, selective endothelin type A (ETA) receptor antagonist which is used in pulmonary arterial...

 
Email this page

Our Publications

Azmarda (Sacubitril/Valsartan) FAQs

This booklet on frequently asked questions on sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI) provides...

Retefast (Reteplase) Datasheet

This datasheet provides an overview on the pharmacology, clinical efficacy, safety, indications and dosage of reteplase.

The Changing Landscape of CV Risk Reduction - Is LDL Lowering Sufficient: Questions & Answers (Dr. Michael Miller, USA)

Here is a set of questions addressed by Dr. Michael Miller, a renowned cardiologist and lipidologist during the “PROMISE” meet held in India.

Pulmonary Hypertension – An Update

This article summarises the definition, classification, pathogenesis, assessment, prognosis, diagnosis and treatment for PH.

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Managing Your Angina

It explains the causes, risk factors, symptoms and treatment options for angina, as well as the various do’s and don’t’s in a patient-friendly...

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
18% (2 votes)
20-40%
18% (2 votes)
40-50%
9% (1 vote)
50-70%
9% (1 vote)
70-80%
36% (4 votes)
Almost all
9% (1 vote)
Total votes: 11